Despite the current coronavirus crisis, deals are being prepped.
Thomas Friedman recently argued that “the coronavirus will create a new historical divide: before-Corona (BC) and after-Corona (AC).”
COVID-19 crisis could bode well for new M&A tech opportunities and Gryphon launches sixth fund.
Amid the COVID-9 crisis, some firms are invoking the MAC clause to pull out of deals.
Thoma Bravo shuts down Imprivata process amid coronavirus downturn, LPs assess risk of ‘nightmare...
Thoma Bravo calls off its potential $2 billion-plus sale of Imprivata amid the coronavirus pandemic and New York State Common Retirement Fund commits to a $2 billion co-investment fund with Neuberger Berman.
MiddleGround is paying leave for employees who test positive for COVID-19 and trying to de-stress during a period of excessive stress.
Telehealth tackles the coronavirus and CapVest-backed Curium calls off its potential $3 billion sale.
Leonard Green partners commit $10 million for an employee-assistance fund and a placement agent is surprisingly optimistic about the long-term effects of the coronavirus outbreak on private equity fundraising
Tech-focused GPS are adjusting to the new coronavirus reality and CapVest's Curium calls off its potential $3 billion sale.
Markets crash amid the coronavirus outbreak and Black Diamond taps an ex-Carlyle exec to head private equity.